NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-09-09 23:58இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Sarthak Metals Reports Demise of Chief Financial Officer Narendra Dewangan
Sarthak Metals Limited has announced the sad demise of its Chief Financial Officer, Mr. Narendra Dewangan, on September 09, 2026. Mr. Dewangan had spent approximately two decades with the company and the Desraj Bansal Group, previously serving as Head of Accounts before his recent elevation to CFO. The company generated Rs 55.21 cr in revenue and Rs 1.33 cr in net profit in Q1 FY27 (quarter ended June 2026). The sudden loss creates a vacancy in the top financial leadership position.
உச்சம் நம்பிக்கை
என்ன மாறியதுDemise of Chief Financial Officer Mr. Narendra Dewangan effective September 09, 2026.
ஏன் இது முக்கியம்The CFO is a Key Managerial Personnel (KMP) responsible for accounting integrity, regulatory filings, and financial discipline; his sudden loss requires a timely succession plan.
Date of cessation: 09th செப்டம்பர், 2026Tenure with group: two decadesQ1 FY27 Revenue: Rs 55.2123 கோடி
📅 குறுகிய காலம்Short-term operational disruption should be minimal, but the board must initiate a search to fill the statutory CFO vacancy.
📈 நீண்ட காலம்Limited, provided the company executes a smooth leadership transition given its established accounting infrastructure.
⚠ அபாய எச்சரிக்கைகள்
Key managerial vacancy in senior financial management
Succession execution risk
👀 கவனிக்க வேண்டியவை
Track subsequent exchange filings regarding the appointment of an interim or permanent Chief Financial Officer to oversee financial reporting and capital allocation.
SMLT Q1 FY27: Revenue Up 19% YoY to ₹55.21 Cr; Welding Volumes Surge 94%
Sarthak Metals reported a 19% YoY revenue growth to ₹55.21 crore for Q1 FY27, driven by strong performance in the welding and cored wire segments. However, EBITDA margins contracted by 99 bps YoY to 2.81%, leading to a 12% decline in operating profit. The welding division is emerging as a key growth engine, with volumes nearly doubling to 458 tonnes and a revenue contribution of ₹5.1 crore. Management has adopted a 'measured approach' to the Biotech segment, limiting investment to ₹50 lakhs so far due to overcapacity in the ethanol industry.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is pivoting growth focus toward the welding consumables segment (import substitution) while slowing down its planned Biotech expansion to maintain capital discipline.
ஏன் இது முக்கியம்The welding segment offers higher growth potential and diversification from the cyclical steel-linked cored wire business, but margin pressure remains a concern in the short term.
Revenue (Q1 FY27): ₹55.21 கோடிWelding Revenue Growth (YoY): 89%EBITDA லாப வரம்பு: 2.81%Biotech Investment to Date: ₹0.50 கோடிFY27 Welding Sales Target: ₹25 கோடிWorking Capital Days (FY26): 173 நாட்கள்
📅 குறுகிய காலம்The stock may face pressure due to the 38% QoQ decline in EBITDA and margin compression, despite the YoY revenue growth.
📈 நீண்ட காலம்Long-term value depends on the successful scaling of the welding division to ₹25cr+ and the stabilization of the aluminum scrap supply chain.
⚠ அபாய எச்சரிக்கைகள்
Raw material volatility (Aluminum scrap)
High working capital cycle (173 days)
Cyclicality in the steel and infrastructure sectors
👀 கவனிக்க வேண்டியவை
Watch for the welding division's ability to hit the ₹25 crore FY27 revenue target and whether the company can pass on rising aluminum scrap costs in the flipping coil segment.
SMLT Q1 Results: PAT up 25% YoY to ₹1.33 Cr; Revenue grows 19% to ₹55.2 Cr
Sarthak Metals Limited (SMLT) reported a 19.4% YoY increase in revenue from operations to ₹55.21 Cr for the quarter ended June 30, 2026. Net profit grew 25.3% YoY to ₹1.33 Cr, although it saw a sequential decline from ₹1.49 Cr in the March 2026 quarter. Finance costs more than doubled to ₹25.59 Lakhs, indicating higher working capital or debt servicing requirements. The company remains a single-segment player in 'Cored Wires' for now, despite previous strategic mentions of diversifying into welding and biotech.
உச்சம் நம்பிக்கை
என்ன மாறியதுSMLT has reported its first-quarter financial results for FY27 and reconstituted its board committees (Audit, NRC, SRC, and CSR) effective August 24, 2026.
ஏன் இது முக்கியம்The YoY growth in a cyclical industry is a positive sign, but the sequential dip in revenue and profit suggests cooling demand or pricing pressure compared to the preceding quarter. The reconstitution of committees is a routine governance update.
📅 குறுகிய காலம்The stock may see neutral-to-positive sentiment due to YoY growth, though the sequential decline (QoQ) in profit from ₹1.49 Cr to ₹1.33 Cr might temper the reaction.
📈 நீண்ட காலம்Long-term value depends on the company's ability to successfully scale its non-cored wire segments (Welding and Biotech) to mitigate the cyclicality of the steel sector.
⚠ அபாய எச்சரிக்கைகள்
Significant increase in finance costs (up 110% YoY)
Single-segment concentration risk
Cyclicality of the steel and infrastructure sectors
👀 கவனிக்க வேண்டியவை
Investors should monitor the contribution of the new Welding and Biotech divisions in upcoming quarters, as the current filing still classifies operations under a single segment. Watch for the impact of raw material price volatility on the 9-10% EBITDA margin target for the welding division.
Sarthak Metals Q4 FY26: PAT Surges 123% YoY to ₹1.49 Cr, Revenue Up 29%
Sarthak Metals Limited (SMLT) reported a robust performance for Q4 FY26, with revenue from operations growing 29% YoY to ₹61.99 crore. Net profit (PAT) saw a significant jump of 123% YoY to ₹1.49 crore, driven by strong volume growth across all major segments. The newly established welding division emerged as a key growth driver, contributing ₹15.7 crore in its first full year of operations. While EBITDA margins improved by 120 bps YoY to 4.04%, the company remains cautious regarding its biotechnology venture due to potential overcapacity in the ethanol industry.
முக்கிய அம்சங்கள்
Revenue from operations increased 29% YoY to ₹61.99 crore in Q4 FY26.Net Profit (PAT) grew by 123% YoY to ₹1.49 crore with EPS rising to ₹1.09.Cored Wire volumes increased 32% YoY to 1,834 tonnes in Q4 FY26.Welding division volumes surged 115% YoY to 432 tonnes, with RDSO approval received in April 2025.EBITDA (excluding other income) rose 84% YoY to ₹2.51 crore, reflecting improved operational efficiency.
👀 கவனிக்க வேண்டியவை
Investors should focus on the scaling of the welding division and its impact on overall margins, as it provides an import substitution opportunity. The stock remains a growth play in the steel-ancillary space, though absolute margins are currently thin at 4%.
Sarthak Metals Reports FY26 Results; Total Assets Grow to ₹137 Crore
Sarthak Metals Limited (SMLT) reported its audited financial results for the fiscal year ending March 31, 2026, showing a 10.1% increase in total assets to ₹137.01 crore. The company's equity base strengthened to ₹124.28 crore, although it took on new current borrowings of ₹6.60 crore. A significant rise in trade receivables to ₹56.85 crore and inventories to ₹39.24 crore suggests increased business activity but may indicate a tighter working capital cycle. The board also approved material related-party transactions with Bansal Brothers for the upcoming fiscal year.
முக்கிய அம்சங்கள்
Total assets increased to ₹13,701.36 Lakhs from ₹12,443.63 Lakhs year-on-year.Trade receivables rose significantly by 33.9% to ₹5,685.35 Lakhs.Inventories grew by 43% to ₹3,924.29 Lakhs, indicating higher stock levels.Current borrowings increased to ₹659.92 Lakhs from zero in the previous year.Statutory auditors issued an unmodified opinion on the standalone financial results.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's working capital management, specifically the rising trade receivables and inventory levels, to ensure efficient cash flow. The introduction of short-term debt after a debt-free period last year warrants a closer look at the upcoming cash flow statements.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Sarthak Metals Limited (SMLT) reported a steady Q3 FY26 performance with revenue from operations increasing 8% YoY to ₹47.73 crore and PAT rising 6% YoY to ₹1.30 crore. The core Cored Wire segment maintained stability with a 1% volume growth, while the new Welding division showed exceptional momentum with volumes surging 182% YoY to 409 tonnes. However, the Aluminium Flipping Coil segment faced significant headwinds, with volumes declining 37% YoY due to unethical competition and pricing distortions. The company is actively diversifying, with its Biotechnology pilot facility in Nagpur now operational and targeting the ethanol sector.
முக்கிய அம்சங்கள்
Revenue from operations grew 8% YoY to ₹47.73 Cr and 31% QoQ, indicating a strong sequential recovery.Welding business achieved ₹4.4 Cr revenue in Q3 with volumes of 409 tonnes, aiming for ₹25 Cr annual sales within two years.EBITDA margins saw a slight contraction of 27 bps YoY to 4.41% due to international price disparities and raw material challenges.Aluminium Flipping Coil segment revenue stood at ₹6 Cr, but operations are currently subdued due to unviable market pricing.Biotechnology initiative is progressing with a 14 kg pilot facility operational in Nagpur and discussions ongoing with ethanol distilleries.
👀 கவனிக்க வேண்டியவை
Investors should focus on the rapid scaling of the Welding division and the progress of the Biotechnology pilot as potential margin drivers. While the core steel-related segments face competitive and pricing pressures, the company's diversification strategy into import-substitution products like flux-cored wires warrants a watch.
Sarthak Metals Q3 FY26 Net Profit Rises 6.3% YoY to ₹1.30 Crore; Revenue Up 8.5%
Sarthak Metals Limited (SMLT) reported a steady performance for the quarter ended December 31, 2025, with revenue from operations growing 8.5% YoY to ₹47.73 crore. Net profit for the quarter saw a modest increase to ₹1.30 crore, up from ₹1.22 crore in the corresponding quarter of the previous year. The company continues to maintain a strong financial position with zero debt across all categories. For the nine-month period ended December 2025, the company achieved a total income of ₹131.55 crore and a net profit of ₹3.12 crore.
முக்கிய அம்சங்கள்
Revenue from operations increased to ₹4,772.94 lakhs in Q3 FY26 compared to ₹4,399.70 lakhs in Q3 FY25.Net profit for the quarter stood at ₹129.72 lakhs, reflecting a 6.3% growth over the previous year's ₹122.02 lakhs.The company remains completely debt-free with zero outstanding loans or debt securities as of December 31, 2025.Earnings Per Share (EPS) for the quarter improved to ₹0.95 from ₹0.92 YoY.Inventory levels rose significantly to ₹3,765.76 lakhs from ₹2,742.11 lakhs in March 2025, suggesting preparation for higher demand.
👀 கவனிக்க வேண்டியவை
The company's debt-free status and consistent profitability in a niche segment like cored wires make it a stable small-cap play. Investors should monitor if the high inventory levels translate into stronger sales growth in the final quarter of the fiscal year.
Sarthak Metals Expands Business Scope into Biotech and Specialty Chemicals via MOA Amendment
Sarthak Metals Limited (SMLT) has received shareholder approval to significantly diversify its business operations by adding biotechnology and specialty chemicals to its Memorandum of Association. This strategic shift allows the company to enter high-growth sectors including bio-fertilizers, pharmaceuticals, and nutraceuticals. Additionally, the company has secured the re-appointment of Mr. Sunil Dutt Bhatt as an Independent Director for a second five-year term effective from August 2026. These developments signal a long-term intent to move beyond traditional metal-related activities into diversified industrial segments.
முக்கிய அம்சங்கள்
Shareholders approved the addition of Clause 9 to the MOA to include biotechnology, enzymes, and bio-based chemicals.The new business scope covers R&D, manufacturing, and trading of pharmaceuticals, bio-inputs, and nutraceuticals.Mr. Sunil Dutt Bhatt re-appointed as Independent Director for a 5-year term from August 3, 2026, to August 2, 2031.The expansion includes provisions for technology transfer, consultancy, and contract research services.Resolutions were passed via Postal Ballot which concluded on December 12, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor management's follow-up plans regarding capital allocation and project timelines for the new biotechnology vertical. While diversification reduces cyclical metal risk, the company's execution capability in these specialized sectors will be a key performance driver.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
